OTC Learning Curve
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
more dip thank you
slap slap slap boys - let's take her back up to .20
thanks for the 11s dip guys
nice churn here - nice and steady back to .30
Attention Panic Sellers: as soon as you dump your shares - Willet will post the PR - don't fall for the OkeeDoke!
Nothing has changed.[color=red][/color]
$DIGAF Strong outa the gate!
lookin for a big spike with crypto prices? Or news?
Hot Tip: I am all in $RBNW - don't like this ticker? - then take a hike and stop pestering us professionals with your childish drivel.[color=red][/color]
Anyone here speaking with Conrad Huss?
Ron Zimmerman and team may ultimately sell this entire proprietary insulin manufacturing process to one of the Big Three Insulin makers - Lilly, Novo Nordisk, Sanofi.
Whoever buys into his process will make an additional 20% gross profit - plus discount their insulin below the other two Insulin giants prices -
Zimmerman will contract its insulin manufacturing to one of several new independent insulin factories around the world:
China, India, Brazil, the Middle East, Poland, Russia and the Ukraine are the new countries involved in the production of insulin.
https://www.gea.com/en/stories/production-of-insulin.jsp
Really? Call this number and tell me how this is a scam: (512) 855-7704
www.zbpinc.com
(512) 855-7704
info@zbpinc.com
Their office is in a real commercial business district - not a mailbox
401 Congress Avenue
Austin, TX 78701
Read the FAQ:
FREQUENTLY ASKED QUESTIONS
What is Zimmerman Biopharmaceutical?
ZBP is a biopharmaceutical company that has developed a proprietary technology to manufacture insulin and insulin analog-active pharmaceutical ingredients. Our technology simplifies and accelerates the production process, making our insulin and insulin analogs cost-competitive on a global scale.
What are the company’s goals?
ZBP’s goal is to become a global manufacturer of integrated and biosimilar medicines by leveraging our expertise in protein manufacturing.
How do you expect to accomplish your goals?
ZBP is actively working on receiving all necessary FDA approvals to market our products. Our business strategy includes developing a world-class facility that will manufacture insulin and insulin analogs using ZBP’s proprietary technology in compliance with Good Manufacturing Practices (cGMP).
What are your sales and marketing strategies?
In the U.S., we will commercialize our insulin and insulin analogs through in-house sales and marketing teams. Outside the U.S., we will secure selective partnerships and seek regulatory approvals to manufacture and to distribute our products.
Why now? What’s going on with insulin that I need to be aware of?
The insulin market has not experienced a significant innovation for decades. In the United States and Europe, three major pharmaceutical companies have enjoyed exclusive marketing rights for their insulin products because of strictly enforced intellectual property laws. During this time, insulin product improvements were limited mostly to new delivery and absorption mechanisms such as controlled-dosage pens, extended-release and inhalable insulin products. However, these innovations were largely accompanied by significant price increases. During 2012-2016, a substantial number of patents from major insulin manufacturers expired. This has given ZBP a pathway to seek approval for its biosimilar products and to enter the marketplace with low-cost insulin.
Can you tell me more about your process?
ZBP has proprietary product and process technology for making biosimilar insulin and insulin analogs resulting in significantly lower costs and a go-to-market plan that is faster than existing manufacturing processes.
Tell me about the FDA process.
The type of FDA regulatory process we are approved for promises an accelerated path to market and allows for revenues in 24 -30 months after our capital raise.
Do you hold any patents?
ZBP is actively pursuing patent approval. ZBP owns the rights to our proprietary process and there are no other owners nor patent holders of our process
Tell me more about the company’s upside potential?
We expect that ZBP’s portfolio of human insulin, fast acting insulin, glucagon, glargine will become the product of choice in a marketplace that lacks competition and is known for high end-user prices.
What is the market for your products?
ZBP’s products will first target the global insulin market which was valued at $42.9 billion in 2017 and is expected to reach a market size of $70.6 billion by 2023. Being a cost-leader in this marketplace will enable ZBP to effectively achieve rapid and deep market penetration.
Do you have FDA approval?
ZBP is aggressively pursuing regulatory approvals for its insulin and insulin analogs using a biosimilar pathway. We are also pursuing patent approval.
Who is leading the company?
ZBP’s management has extensive experience in the biopharmaceutical and drug manufacturing industry with a demonstrated track record in delivering products through FDA.
Dr. Ron Zimmerman has over 40 years of experience in the protein chemistry field and more than 15 years of working on insulins.
Mr. David Wood has over 35 years of leadership experience with nearly 20 years in executive leadership roles that involved creation of substantial shareholder value.
Ms. Donna Zimmerman has over 30 years of experience in the clinical area monitoring clinical trials, managing FDA approval processes, Investigational New Drug (IND) application process and New Drug Application (NDA) process.
Are you raising money right now?
Yes! We are actively raising capital to bring our products to market. Please contact us at info@zbpinc.com if you are interested in participating as an investor.
$SSOF TA confirmed SS yesterday: ZERO DILUTION - ZERO DEBT!
Share Structure
Market Cap Market Cap
1,119,986
11/14/2019
Authorized Shares
1,000,000,000
11/14/2019
Outstanding Shares
699,991,000
11/14/2019
Restricted
110,750,000
11/14/2019
Unrestricted
589,241,000
11/14/2019
Held at DTC
533,422,641
11/14/2019
Float
489,421,431
06/30/2019 [color=red][/color]
$SSOF CEO bio:
"Mr. David Wood leads Zimmerman BioPharmaceuticals as President and CEO with 35+ years experience as an operations executive in start-ups and Fortune 25 companies; delivering rapid revenue growth, and building teams to sustain growth & profitability. He was the CRO for Scient Inc., VP & GM for the $180 million Enterprise BU, and the President & COO for The Joseph Company valued at $40 million. He served as a Captain in the United States Army, and holds a Bachelor of Science, Magna Cum Laude, from Northeastern University."
Dr. Ron Zimmerman is the Founder and Chief Science Officer of Zimmerman BioPharmaceuticals. Dr. Zimmerman served as the Chief Scientist at Eli Lilly for more than 30 years. His career in the biopharma industry also includes 20 years of building and selling biopharmaceutical businesses, where he developed and patented processes that greatly improve insulin manufacturing. Dr. Zimmerman served as the co-founder and President of IPT, Inc., which sold to IVAX Corporation at a 500% internal rate of return (IRR). IVAX later sold to Teva Pharmaceutical Industries for $7.4 billion (Nasdaq: TEVA)
looking forward to seeing the fresh DD - although I am loaded and still accumulating - This is way bigger than a penny company.[color=red][/color]
$SSOF - BUY BUY BUY
1. Proprietary Insulin manufacturing process -
2. Game changer for insulin market -
3. Patent-Applied for) -
4. Novo Nordisk & Lilly will be forced to buy out
5. +1000% run very soon
6. Buy now @ .0018
7. No Debt
9. Name Change
10. ????????????????????
$SSOF FAQ here: https://www.zbpinc.com/faq
You guys should read this instead of listening to posters with agendas on the board. I am continuing to load - this will make alot of people wealthy IMHO
exactly - like clockwork - but of course, give it a couple days and we go right back up. will be awesome if we can see some quick filings pout of the gate
Excellent FAQ!!!!! post the link on twitter?
Guys - the product and business model is simple: we own a patented process that makes it 50% cheaper to manufacture insulin and sell it 50% cheaper (1/2 price) than all other insulins - this will quickly be bought out by Eli Lilly or Novo Nordisk - because it would kill their insulin business.
This is a great investment opportunity at .002.
$SSOF WEBSITE IS LIVE! https://www.zbpinc.com/
BRAND NEW WEBSITE IS NOW LIVE - what the heck are you saying? You must have mistyped the correct URL address.
$HIRU - your patience will pay off big time 200%-500% ROI - IMHO
$RKLC - LOADING ZONE - sellers gonna be sad
$HMLA about to explode north $$$$
$HMLA - spoke with JC yesterday - $HMLA confirmed his position with $HMLA myself. This is goping back up as we speak. Look for new highs.
Quote Tweet[color=red][/color]
Hi Justin, question: are you still involved with $HMLA? If so, why not support the board and or kick up some price support?
Just loaded another 200K shares! Thanks for your suggestion!
$HMLA - Shorts DESPERATE! LMAO
$HIRU is a legal non-filer - https://www.otcmarkets.com/filing/html?id=1693142&guid=Q9MfUaKC2is1bth
sorry, don't have DM capability on ihub
apostle, never mind just saw the CD on OTCmarkets - any inside info as to when this will be cleared up?
can you explain exactly what you think is happening with the price beatdown this morning? is there some problem between mina--- and xu? or????
$LIBE 92% all BUYS today
you can verify this right here on IHUB in "quotes, tyhen "trades"
$LIBE LOAD LOAD LOAD - TIC TOC
$LIBE - PATIENCE - ACCUMULATE - HOLD FOR NEXT PR & 8KS
I BELIEVE MILLIONAIRE$ WILL BE MADE HERE
$LIBE - ATTENTION Shareholders: [color=red][/color] I just spoke with Ed Carter, CEO for NGEN/LIBE. Ed and Cliff Rhee have dedicated 14 years (2005) to developing NGEN technologies & patents.
Quoted Facts: "NO R/S near term - yes, the orders from Hyundai are 100% real & AUDITED"
RETWEET
Whales are buying your fear shares right now - $LIBE is going into the high .00s - don't panic - the only hesitation is people still worrying about all those old LIBE twists and turns that didn't pan out - when the bottom stays solid today, whale traders will drive this up to the high double zeros $.005 - .007[color=red][/color]
Thanks to whoever is unloading those 10mil .0011s! pure liquid gold.
We going up big time from here - folks have no idea yet
good riddance
$DCGD - ALL IN BABY!!!! GOING LONG[color=red][/color]